 Penumbras operating performance has been up to par lately, including better-than-expected gross margins, but a rerating of growth med-tech has hit the shares harder than most. Management is trying to achieve a delicate balancing act between investing in REAL VR a high-potential immersive technology platform for neuro and psychological rehab and boosting near-term profitability. 